Abstract
Genistein, as a kind of natural inhibitor of tyrosine-specific protein kinases from soybean extracts, has been proved to be closely related to the development of various malignancy tumors such as breast cancer, ovarian cancer and prostate cancer. Studies in vivo and in vitro have indicated that Genistein can inhibit tumor proliferation, invasion and metastasis, induce apoptosis and has the function of anti-angiogenesis by combining with estrogen receptor in order to play anti-cancer effect, which suggest that Genistein may become a new drug in clinical treatment of tumor in the future. Key words: Neoplasms; Molecular mechanisms of pharmacological action; Genistein
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
